FOLFOX 4 療法における末梢神経障害発症に関与する臨床的因子の検討
Saved in:
| Published in | 医療薬学 Vol. 36; no. 5; pp. 347 - 351 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人日本医療薬学会
2010
|
| Online Access | Get full text |
| ISSN | 1346-342X 1882-1499 |
| DOI | 10.5649/jjphcs.36.347 |
Cover
| Author | 葉山, 達也 中山, 敏光 吉田, 善一 早坂, 正敏 今井, 徹 中馬, 真幸 濃沼, 政美 丹正, 勝久 |
|---|---|
| Author_xml | – sequence: 1 fullname: 今井, 徹 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 早坂, 正敏 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 中馬, 真幸 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 葉山, 達也 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 中山, 敏光 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 吉田, 善一 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 丹正, 勝久 organization: 日本大学医学部附属板橋病院薬剤部 – sequence: 1 fullname: 濃沼, 政美 organization: 日本大学薬学部 |
| BookMark | eNo9kEFLAkEAhYcwyMxjd__A2szOzO7OsSQrELwUSJdlZp1NFzPZ9dJxJRA0pA4VmkRIgSB5kSD8O9vu6r9IULq89-B9vMPbBYn6TV0CsI9glmqEHThOo2J5WaxlMdG3QBIZhqogwlhilTHRFEzU0g5Ie15VQIgR0hBlSXCZLxbyxVKGZOJ-K5o9Bf4k8DuB_xi0utFwEo1G8edb_H2_HAzD6Szuz-OX9opZPo9-f3qB319hi_Y4nHfiwV34-h5-PQT-NPoYLsa9PbBt85on0xtPgYv88XnuVCkUT85yhwXFUSmEiiSQY8hVJDQdUm5jhKVqWzrjWDBpiLKtMsNmRApbxUbZENKSuhAGlVijlqA4BY7Wu47X5FfSbLjVa-7emtxtVq2aNNfPmFgz6UaI_l9aFe6aDsd_yvF-gQ |
| ContentType | Journal Article |
| Copyright | 2010 日本医療薬学会 |
| Copyright_xml | – notice: 2010 日本医療薬学会 |
| DOI | 10.5649/jjphcs.36.347 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1882-1499 |
| EndPage | 351 |
| ExternalDocumentID | article_jjphcs_36_5_36_5_347_article_char_ja |
| GroupedDBID | .LE 5GY ABJNI ALMA_UNASSIGNED_HOLDINGS KQ8 MOJWN RJT |
| ID | FETCH-LOGICAL-j2500-e40a30a21b6705af313e2fc79a3b9e8bdf298f94ebf238d8bece7bb85e365cb53 |
| ISSN | 1346-342X |
| IngestDate | Wed Sep 03 06:20:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 5 |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2500-e40a30a21b6705af313e2fc79a3b9e8bdf298f94ebf238d8bece7bb85e365cb53 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/jjphcs/36/5/36_5_347/_article/-char/ja |
| PageCount | 5 |
| ParticipantIDs | jstage_primary_article_jjphcs_36_5_36_5_347_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 20100000 |
| PublicationDateYYYYMMDD | 2010-01-01 |
| PublicationDate_xml | – year: 2010 text: 20100000 |
| PublicationDecade | 2010 |
| PublicationTitle | 医療薬学 |
| PublicationTitleAlternate | 医療薬学 |
| PublicationYear | 2010 |
| Publisher | 一般社団法人日本医療薬学会 |
| Publisher_xml | – name: 一般社団法人日本医療薬学会 |
| References | 5)今田洋司,川上和宜,平岡知子,樋口秀太郎,高橋郷,青山剛,篠崎英司,末永光邦,松坂諭,濱敏弘,FOLFOX4療法の副作用集計データに基づく患者向け説明文書の作成,癌と化学療法,34,1425-1430 (2007). 9)A.Grothey,Oxliplatin-safety profile : neurotoxicity,Semin.Oncol .,30,5-13 (2003). 2)A.Grothey,Clinical management of oxialiplatin-associated neurotoxicity,Clin.Colorectal Cancer ,5,38-46 (2005). 4)A.Grothey,D.Sargent,R.M.Goldberg,H.M.Schmoll,Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin,irinotecan,and oxaliplatin in the course of treatment,J.Clin.Oncol .,22,1209-1214 (2004). 12)S.Cascinu,V.Catalano,L.Cordella,R.Labianca,P.Giordani,A.M.Baldelli,G.D.Beretta,E.Ubiali,G.Catalano,Neuroprotective effect of reduced glutathione on oxaliplatinbased chemotherapy in advanced colorectal cancer : a randomized,double-blind,placebo-controlled trial,J.Clin.Oncol .,20,3478-3483 (2002). 10)L.Gamelin,M.Boisdron-Celle,R.Delva,V.Guerin-Meyer,N.Ifrah,A.Morel,E.Gamelin,Prevention of oxaliplatinrelated neurotoxicity by calcium and magnesium infusions : a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer,Clin.Cancer Res .,10,4055-4061 (2004). 13)C.Tournigand,A.Cervantes,A.Figer,G.Lledo,M.Flesch,M.Buyse,L.Mineur,E.Carola,P.L.Etienne,F.Rivera,I.Chirivella,N.Perez-Staub,C.Louvent,T.Andre,I.TabahFisch,A.de Gramont,OPTIMOX 1 : a randomized study of FOLFOX 4 or FOLFOX 7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancecer -a GERCOR study,J.Clin.Oncol .,24,394-400 (2006). 8)A.de Gramont,A.Figer,M.Seymour,M.Homerin,A.Hmissi,J.Cassidy,C.Boni,H.Cortes-Funes,A.Cervantes,G.Freyer,D.Papamichael,N.Le Bail,C.Louvet,D.Hendler,F.de Braud,C.Wilson,F.Morvan,A.Bonetti,Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,J.clin.oncol .,18,2938-2947 (2000). 6)吉村知哲,木村美智男,岩井美奈,宇佐美英績,中尾俊也,安田忠司,進行·再発大腸がんに対するFOLFOX4療法の安全性評価,医療薬学,33,520-525 (2007). 1)“大腸癌治療ガイドライン医師用2005年度版”,大腸癌研究会編,金原出版,2005,pp.29-33. 14)C.Tournigand,T.Andre,E.Achille,G.Lledo,M.Flesh,D.Mery-Mignard,E.Quinaux,C.Couteau,M.Buyse,G.Ganem,B.Landi,P.Colin,C.Louvet,A.De Gramont,FOLFIRI followed by FOLFOX 6 or the reverse sequence in advanced colorectal cancer : a randomized GERCOR study.J.Clin.Oncol .,22,229-237 (2004). 11)C.Lersch,R.Schmelz,F.Eckel,J.Erdmann,M.Mayr,E.Schuite-Frohlinde,S.Quasthoff,J.Grosskreutz,H.Adelsberger,Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer,Clin.Colorectal Cancer ,2,54-58 (2002). 3)R.J.Cersosimo,Oxalipatin-associated neuropathy : a review,Ann.Pharmacother .,39,128-135 (2005). 7)オキサリプラチン(エルプラット)注医薬品インタビューフォーム,ヤクルト株式会社,2009年1月改訂版. |
| References_xml | – reference: 8)A.de Gramont,A.Figer,M.Seymour,M.Homerin,A.Hmissi,J.Cassidy,C.Boni,H.Cortes-Funes,A.Cervantes,G.Freyer,D.Papamichael,N.Le Bail,C.Louvet,D.Hendler,F.de Braud,C.Wilson,F.Morvan,A.Bonetti,Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer,J.clin.oncol .,18,2938-2947 (2000). – reference: 14)C.Tournigand,T.Andre,E.Achille,G.Lledo,M.Flesh,D.Mery-Mignard,E.Quinaux,C.Couteau,M.Buyse,G.Ganem,B.Landi,P.Colin,C.Louvet,A.De Gramont,FOLFIRI followed by FOLFOX 6 or the reverse sequence in advanced colorectal cancer : a randomized GERCOR study.J.Clin.Oncol .,22,229-237 (2004). – reference: 11)C.Lersch,R.Schmelz,F.Eckel,J.Erdmann,M.Mayr,E.Schuite-Frohlinde,S.Quasthoff,J.Grosskreutz,H.Adelsberger,Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer,Clin.Colorectal Cancer ,2,54-58 (2002). – reference: 10)L.Gamelin,M.Boisdron-Celle,R.Delva,V.Guerin-Meyer,N.Ifrah,A.Morel,E.Gamelin,Prevention of oxaliplatinrelated neurotoxicity by calcium and magnesium infusions : a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer,Clin.Cancer Res .,10,4055-4061 (2004). – reference: 5)今田洋司,川上和宜,平岡知子,樋口秀太郎,高橋郷,青山剛,篠崎英司,末永光邦,松坂諭,濱敏弘,FOLFOX4療法の副作用集計データに基づく患者向け説明文書の作成,癌と化学療法,34,1425-1430 (2007). – reference: 2)A.Grothey,Clinical management of oxialiplatin-associated neurotoxicity,Clin.Colorectal Cancer ,5,38-46 (2005). – reference: 7)オキサリプラチン(エルプラット)注医薬品インタビューフォーム,ヤクルト株式会社,2009年1月改訂版. – reference: 3)R.J.Cersosimo,Oxalipatin-associated neuropathy : a review,Ann.Pharmacother .,39,128-135 (2005). – reference: 1)“大腸癌治療ガイドライン医師用2005年度版”,大腸癌研究会編,金原出版,2005,pp.29-33. – reference: 6)吉村知哲,木村美智男,岩井美奈,宇佐美英績,中尾俊也,安田忠司,進行·再発大腸がんに対するFOLFOX4療法の安全性評価,医療薬学,33,520-525 (2007). – reference: 13)C.Tournigand,A.Cervantes,A.Figer,G.Lledo,M.Flesch,M.Buyse,L.Mineur,E.Carola,P.L.Etienne,F.Rivera,I.Chirivella,N.Perez-Staub,C.Louvent,T.Andre,I.TabahFisch,A.de Gramont,OPTIMOX 1 : a randomized study of FOLFOX 4 or FOLFOX 7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancecer -a GERCOR study,J.Clin.Oncol .,24,394-400 (2006). – reference: 4)A.Grothey,D.Sargent,R.M.Goldberg,H.M.Schmoll,Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin,irinotecan,and oxaliplatin in the course of treatment,J.Clin.Oncol .,22,1209-1214 (2004). – reference: 9)A.Grothey,Oxliplatin-safety profile : neurotoxicity,Semin.Oncol .,30,5-13 (2003). – reference: 12)S.Cascinu,V.Catalano,L.Cordella,R.Labianca,P.Giordani,A.M.Baldelli,G.D.Beretta,E.Ubiali,G.Catalano,Neuroprotective effect of reduced glutathione on oxaliplatinbased chemotherapy in advanced colorectal cancer : a randomized,double-blind,placebo-controlled trial,J.Clin.Oncol .,20,3478-3483 (2002). |
| SSID | ssib003116159 ssib002484604 ssib000871962 ssib060196744 ssj0069027 ssib005902156 ssib023157658 |
| Score | 1.7899925 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 347 |
| Title | FOLFOX 4 療法における末梢神経障害発症に関与する臨床的因子の検討 |
| URI | https://www.jstage.jst.go.jp/article/jjphcs/36/5/36_5_347/_article/-char/ja |
| Volume | 36 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 医療薬学, 2010, Vol.36(5), pp.347-351 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NS9xANIi99FL6Sb_ZQ8eLrk12JpkZekrWLNIvLShIL0uym1D2YKXqwd5WCoIt0h7aopVSpAVB6kUKxb-z3V39F33vTdaNpQdtIYRh8uZ9TjLvTWbeWNadyI4iWavJYiTwCLPUToqxI2pFPNBYJzAgyxJucH702BufFvdn3JmBwYHcqqXFhXi09vKv-0r-xapQB3bFXbKnsOwRUqiAMtgX7mBhuJ_IxpWJh5WJmWExzELJtGaqxEKPBZxpl4UcnETmB1lB-VlBO1QoMRUgsC4TjMf8El6Ax3eZDrEQuEyVWaiZ9hEsdJkfInJDK_CpIJmSOVoATKhCwQLFVNgjqnNEFTbxFSIEJMrggYLAGh0w3yZaY0zbPcwhcSiIDYVtVZj3qhEeWA2CnB4UcVLOUPlHE5DEWkBkBdIHVUEvI2ZAOt0H81A4XxNTY4iSwDzCxukxEK0cQ6vwIejAJ8oEL5FnXSH8oDTVh1doCkX4AwcvgtekLkHoQJmV_KxMtjIX36Cegm1SpyJBJWoIhMi0yHN9gSRFixmh3J7lyyfRHDUHIfzcAMaFV-SCjqiH8d3UYRQFkbDOj3om7Uz2dru5IYybDKiZN8RNOuA_B1rXE5inttGYe1abH-Xe6FGrY7nLszejauCq3Ku62U3Iau8hbi-sNiDGOVOS0sFluQ-e5EMECYNE7s-_AI85N4XAHYxZcinoNHqxRy42hC8QUff__HuYD4pOfDDemgfgdABTT28mDy_Kd_eYdOChNiBe6631JPdz6rx1LosbC76R5oI10IguWkOTJvH80khhqr-Pcn6kMFSY7KekX7pkPTVfioIodNeXO3vvW82dVnO11XzXWn7d2dzpbG11v33u_nhzuLHZ3t3rru93P64AzOGHrV8_11rNdQA7WNlu7692N161P31pf3_bau52vm4ebK9dtqYr4VR5vJidqlJsQLhjFxNhR9yOSk7sSduNUu7wpJTWpI54rBMV19OSVqkWSZyCO19X8JFPZBwrN-GeW4tdfsUanH0-m1y1CrELkNxOpZPaInU8JdJ6XfHIiWSi3Tq_Zt0zOqvOmdQ51dN0iOv_1fqGddYs9MHZ0pvW4MKLxeQWxA8L8W3qYL8BYVTpuA |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FOLFOX+4+%E7%99%82%E6%B3%95%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B%E6%9C%AB%E6%A2%A2%E7%A5%9E%E7%B5%8C%E9%9A%9C%E5%AE%B3%E7%99%BA%E7%97%87%E3%81%AB%E9%96%A2%E4%B8%8E%E3%81%99%E3%82%8B%E8%87%A8%E5%BA%8A%E7%9A%84%E5%9B%A0%E5%AD%90%E3%81%AE%E6%A4%9C%E8%A8%8E&rft.jtitle=%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6&rft.au=%E4%BB%8A%E4%BA%95%2C+%E5%BE%B9&rft.au=%E6%97%A9%E5%9D%82%2C+%E6%AD%A3%E6%95%8F&rft.au=%E4%B8%AD%E9%A6%AC%2C+%E7%9C%9F%E5%B9%B8&rft.au=%E8%91%89%E5%B1%B1%2C+%E9%81%94%E4%B9%9F&rft.date=2010&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%99%82%E8%96%AC%E5%AD%A6%E4%BC%9A&rft.issn=1346-342X&rft.eissn=1882-1499&rft.volume=36&rft.issue=5&rft.spage=347&rft.epage=351&rft_id=info:doi/10.5649%2Fjjphcs.36.347&rft.externalDocID=article_jjphcs_36_5_36_5_347_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-342X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-342X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-342X&client=summon |